Corwin v. Boehringer Ingelheim Pharmaceuticals, Inc.
Plaintiff / Appellee: John Corwin
Defendant / Appellant: Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim Corporation, Boehringer Ingelheim USA Corporation, GlaxoSmithKline LLC, Glaxosmithkline Holdings (Americas), Inc., Pfizer, Inc., Sanofi-Aventis U.S. LLC and Sanofi US Services Inc.
Case Number: 23-881
Filed: June 13, 2023
Court: U.S. Court of Appeals, Second Circuit
Nature of Suit: Torts
RSS RSS Track this Docket
Docket Report

This docket was last retrieved on July 18, 2023. A more recent docket listing may be available from PACER.

Date Filed Document Text
July 18, 2023 Filing 77 CURED DEFECTIVE JOINT APPENDIX, volumes 1-5, [ # 70 ], [ # 71 ], [ # 72 ], [ # 73 ], [ # 74 ], on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, FILED.[3543230] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/18/2023 02:46 PM]
July 18, 2023 Filing 76 CURED DEFECTIVE BRIEF & SPECIAL APPENDIX, [ # 69 ], on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, FILED.[3543227] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/18/2023 02:44 PM]
July 18, 2023 Filing 75 MOTION ORDER, granting motion to adjourn oral argument [ # 66 ] filed by Appellant Sanofi-Aventis U.S. LLC and Sanofi US Services Inc. in 23-877, FILED. [3543211][75] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/18/2023 02:35 PM]
July 18, 2023 Filing 74 JOINT APPENDIX, volume 5 of 5, (pp. 1036-1307), on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885, FILED. Service date 07/18/2023 by CM/ECF.[3543205] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/18/2023 02:30 PM]
July 18, 2023 Filing 73 JOINT APPENDIX, volume 4 of 5, (pp. 780-1035), on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885, FILED. Service date 07/18/2023 by CM/ECF.[3543199] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/18/2023 02:28 PM]
July 18, 2023 Filing 72 JOINT APPENDIX, volume 3 of 5, (pp. 530-779), on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885, FILED. Service date 07/18/2023 by CM/ECF.[3543196] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/18/2023 02:24 PM]
July 18, 2023 Filing 71 JOINT APPENDIX, volume 2 of 5, (pp. 261-529), on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885, FILED. Service date 07/18/2023 by CM/ECF.[3543192] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/18/2023 02:21 PM]
July 18, 2023 Filing 70 JOINT APPENDIX, volume 1 of 5, (pp. 1-260), on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885, FILED. Service date 07/18/2023 by CM/ECF.[3543189] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/18/2023 02:19 PM]
July 18, 2023 Filing 69 BRIEF & SPECIAL APPENDIX, on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885, FILED. Service date 07/18/2023 by CM/ECF. [3543185] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/18/2023 02:15 PM]
July 18, 2023 Filing 67 CURED DEFECTIVE MOTION, TO ADJOURN ORAL ARGUMENT, [ # 66 ], on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, FILED.[3543083] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/18/2023 12:56 PM]
July 18, 2023 Filing 66 MOTION, to adjourn oral argument, on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885, FILED. Service date 07/18/2023 by CM/ECF. [3543073] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/18/2023 12:52 PM]
July 18, 2023 Filing 62 DEFECTIVE DOCUMENT, Joint Appendix, volumes 1-5, [53], [54], [55], [56], [57], on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, FILED.[3542873] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/18/2023 09:17 AM]
July 18, 2023 Filing 61 DEFECTIVE DOCUMENT, Brief & Special Appendix, [52], on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, FILED.[3542867] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/18/2023 09:06 AM]
July 18, 2023 Filing 60 DEFECTIVE DOCUMENT, MOTION, to adjourn oral argument, [58], on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, FILED.[3542842] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/18/2023 08:43 AM]
July 17, 2023 Filing 58 MOTION, to adjourn oral argument, on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885, FILED. Service date 07/17/2023 by CM/ECF. [3542754] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885]--[Edited 07/18/2023 by RW] [Entered: 07/17/2023 08:06 PM]
July 17, 2023 Filing 57 JOINT APPENDIX, volume 5 of 5, (pp. 1036-1307), on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885, FILED. Service date 07/17/2023 by CM/ECF.[3542747] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/17/2023 07:19 PM]
July 17, 2023 Filing 56 JOINT APPENDIX, volume 4 of 5, (pp. 780-1035), on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885, FILED. Service date 07/17/2023 by CM/ECF.[3542746] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/17/2023 07:15 PM]
July 17, 2023 Filing 55 JOINT APPENDIX, volume 3 of 5, (pp. 530-779), on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885, FILED. Service date 07/17/2023 by CM/ECF.[3542745] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/17/2023 07:13 PM]
July 17, 2023 Filing 54 JOINT APPENDIX, volume 2 of 5, (pp. 261-529), on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885, FILED. Service date 07/17/2023 by CM/ECF.[3542744] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/17/2023 07:10 PM]
July 17, 2023 Filing 53 JOINT APPENDIX, volume 1 of 5, (pp. 1-260), on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885, FILED. Service date 07/17/2023 by CM/ECF.[3542743] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/17/2023 07:08 PM]
July 17, 2023 Filing 52 BRIEF & SPECIAL APPENDIX, on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885, FILED. Service date 07/17/2023 by CM/ECF. [3542742] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/17/2023 07:05 PM]
July 14, 2023 Filing 46 NEW CASE MANAGER, Ronald Willoughby, ASSIGNED.[3541402] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/14/2023 08:45 AM]
July 13, 2023 Filing 40 ATTORNEY, Robert A. Izard Jr. for John Corwin, in case 23-881, [ # 36 ], ADDED.[3541238] [23-881] [Entered: 07/13/2023 04:58 PM]
July 13, 2023 Filing 38 CURED DEFECTIVE Notice of Appearance as Additional Counsel, [ # 32 ], [ # 34 ], on behalf of Appellee John Corwin, FILED.[3541231] [23-881] [Entered: 07/13/2023 04:55 PM]
July 6, 2023 Filing 37 ATTORNEY, Jaime Ashley Welsh for Boehringer Ingelheim Corporation Boehringer Ingelheim USA Corporation Boehringer Ingelheim Pharmaceuticals, Inc., in case 23-881, [ # 23 ], ADDED.[3538105] [23-881] [Entered: 07/06/2023 04:07 PM]
July 5, 2023 Filing 36 NOTICE OF APPEARANCE AS ADDITIONAL COUNSEL, on behalf of Appellee John Corwin, FILED. Service date 07/05/2023 by CM/ECF. [3537370] [23-881] [Entered: 07/05/2023 04:13 PM]
July 5, 2023 Filing 34 NOTICE OF APPEARANCE AS ADDITIONAL COUNSEL, on behalf of Appellee John Corwin, FILED. Service date 07/05/2023 by CM/ECF. [3537259] [23-881] [Entered: 07/05/2023 03:00 PM]
July 5, 2023 Filing 33 DEFECTIVE DOCUMENT, Notice of Appearance as Additional Counsel, [ # 26 ], on behalf of Appellee Jerome Jay Berkowitz, Mary Cassidy, John Corwin, Armando Ramos, Rafael Rolon, Roderick Sullivan, Thomas Vazzano and Anne Yost in 23-877, Appellee Jerome Jay Berkowitz in 23-878, Appellee Armando Ramos in 23-879, Appellee Mary Cassidy in 23-880, Appellee John Corwin in 23-881, Appellee Thomas Vazzano in 23-882, Appellee Rafael Rolon in 23-883, Appellee Roderick Sullivan in 23-884, Appellee Anne Yost in 23-885, FILED.[3537032] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/05/2023 11:21 AM]
July 5, 2023 Filing 32 DEFECTIVE DOCUMENT, Notice of Appearance as Additional Counsel, [ # 25 ], on behalf of Appellee Beth Bacher, Jerome Jay Berkowitz, Mary Cassidy, John Corwin, Armando Ramos, Rafael Rolon, Roderick Sullivan, Thomas Vazzano and Anne Yost in 23-877, FILED.[3537005] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/05/2023 11:09 AM]
June 30, 2023 Filing 31 ATTORNEY, James I. Glasser for Pfizer, Inc., in case 23-881, [ # 22 ], ADDED.[3536520] [23-881] [Entered: 06/30/2023 02:59 PM]
June 30, 2023 Filing 30 ATTORNEY, Lauren R. Greenspoon for Glaxosmithkline Holdings (Americas), Inc. GlaxoSmithKline LLC, in case 23-881, [ # 14 ], ADDED.[3536512] [23-881] [Entered: 06/30/2023 02:54 PM]
June 29, 2023 Filing 26 NOTICE OF APPEARANCE AS ADDITIONAL COUNSEL, on behalf of Appellee Beth Bacher, Jerome Jay Berkowitz, Mary Cassidy, John Corwin, Armando Ramos, Rafael Rolon, Roderick Sullivan, Thomas Vazzano and Anne Yost in 23-877, Appellee Jerome Jay Berkowitz in 23-878, Appellee Armando Ramos in 23-879, Appellee Mary Cassidy in 23-880, Appellee John Corwin in 23-881, Appellee Thomas Vazzano in 23-882, Appellee Rafael Rolon in 23-883, Appellee Roderick Sullivan in 23-884, Appellee Anne Yost in 23-885, FILED. Service date 06/29/2023 by CM/ECF. [3535620] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 06/29/2023 12:04 PM]
June 29, 2023 Filing 25 NOTICE OF APPEARANCE AS ADDITIONAL COUNSEL, on behalf of Appellee Beth Bacher, Jerome Jay Berkowitz, Mary Cassidy, John Corwin, Armando Ramos, Rafael Rolon, Roderick Sullivan, Thomas Vazzano and Anne Yost in 23-877, Appellee Jerome Jay Berkowitz in 23-878, Appellee Armando Ramos in 23-879, Appellee Mary Cassidy in 23-880, Appellee John Corwin in 23-881, Appellee Thomas Vazzano in 23-882, Appellee Rafael Rolon in 23-883, Appellee Roderick Sullivan in 23-884, Appellee Anne Yost in 23-885, FILED. Service date 06/29/2023 by CM/ECF. [3535610] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 06/29/2023 11:49 AM]
June 28, 2023 Filing 24 ELECTRONIC INDEX, in lieu of record, FILED.[3535331] [23-881] [Entered: 06/28/2023 08:37 PM]
June 28, 2023 Filing 23 NOTICE OF APPEARANCE AS ADDITIONAL COUNSEL, on behalf of Appellant Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals, Inc. and Boehringer Ingelheim USA Corporation, FILED. Service date 06/28/2023 by CM/ECF. [3535098] [23-881] [Entered: 06/28/2023 03:12 PM]
June 27, 2023 Filing 22 NOTICE OF APPEARANCE AS ADDITIONAL COUNSEL, on behalf of Appellant Pfizer, Inc., FILED. Service date 06/27/2023 by CM/ECF. [3534566] [23-881] [Entered: 06/27/2023 05:24 PM]
June 27, 2023 Filing 21 FORM D, on behalf of Appellant Pfizer, Inc., FILED. Service date 06/27/2023 by CM/ECF.[3534564] [23-881] [Entered: 06/27/2023 05:23 PM]
June 27, 2023 Filing 20 FORM C, on behalf of Appellant Pfizer, Inc., FILED. Service date 06/27/2023 by CM/ECF.[3534563] [23-881] [Entered: 06/27/2023 05:22 PM]
June 27, 2023 Filing 19 ACKNOWLEDGMENT AND NOTICE OF APPEARANCE, on behalf of Appellant Pfizer, Inc., FILED. Service date 06/27/2023 by CM/ECF.[3534562] [23-881] [Entered: 06/27/2023 05:22 PM]
June 27, 2023 Filing 18 ACKNOWLEDGMENT AND NOTICE OF APPEARANCE, on behalf of Appellee John Corwin, FILED. Service date 06/27/2023 by CM/ECF, email.[3534503] [23-881] [Entered: 06/27/2023 04:40 PM]
June 27, 2023 Filing 17 FORM D, on behalf of Appellant Glaxosmithkline Holdings (Americas), Inc. and GlaxoSmithKline LLC, FILED. Service date 06/27/2023 by CM/ECF.[3534472] [23-881] [Entered: 06/27/2023 04:22 PM]
June 27, 2023 Filing 16 FORM C, on behalf of Appellant Glaxosmithkline Holdings (Americas), Inc. and GlaxoSmithKline LLC, FILED. Service date 06/27/2023 by CM/ECF.[3534469] [23-881] [Entered: 06/27/2023 04:19 PM]
June 27, 2023 Filing 15 ACKNOWLEDGMENT AND NOTICE OF APPEARANCE, on behalf of Appellant Glaxosmithkline Holdings (Americas), Inc. and GlaxoSmithKline LLC, FILED. Service date 06/27/2023 by CM/ECF.[3534465] [23-881] [Entered: 06/27/2023 04:16 PM]
June 27, 2023 Filing 14 NOTICE OF APPEARANCE AS ADDITIONAL COUNSEL, on behalf of Appellant Glaxosmithkline Holdings (Americas), Inc. and GlaxoSmithKline LLC, FILED. Service date 06/27/2023 by CM/ECF. [3534444] [23-881] [Entered: 06/27/2023 04:06 PM]
June 27, 2023 Filing 13 NOTICE OF APPEARANCE AS ADDITIONAL COUNSEL, on behalf of Appellant Glaxosmithkline Holdings (Americas), Inc. and GlaxoSmithKline LLC, FILED. Service date 06/27/2023 by CM/ECF. [3534407] [23-881] [Entered: 06/27/2023 03:41 PM]
June 27, 2023 Filing 12 NOTICE OF APPEARANCE AS ADDITIONAL COUNSEL, on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC, FILED. Service date 06/27/2023 by CM/ECF. [3534376] [23-881] [Entered: 06/27/2023 02:53 PM]
June 27, 2023 Filing 11 FORM D, on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC, FILED. Service date 06/27/2023 by CM/ECF.[3534374] [23-881] [Entered: 06/27/2023 02:51 PM]
June 27, 2023 Filing 10 FORM C, on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC, FILED. Service date 06/27/2023 by CM/ECF.[3534373] [23-881] [Entered: 06/27/2023 02:50 PM]
June 27, 2023 Filing 9 ACKNOWLEDGMENT AND NOTICE OF APPEARANCE, on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC, FILED. Service date 06/27/2023 by CM/ECF.[3534372] [23-881] [Entered: 06/27/2023 02:48 PM]
June 27, 2023 Filing 8 FORM D, on behalf of Appellant Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals, Inc. and Boehringer Ingelheim USA Corporation, FILED. Service date 06/27/2023 by CM/ECF.[3534301] [23-881] [Entered: 06/27/2023 02:06 PM]
June 27, 2023 Filing 7 FORM C, on behalf of Appellant Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals, Inc. and Boehringer Ingelheim USA Corporation, FILED. Service date 06/27/2023 by CM/ECF.[3534299] [23-881] [Entered: 06/27/2023 02:05 PM]
June 27, 2023 Filing 6 ACKNOWLEDGMENT AND NOTICE OF APPEARANCE, on behalf of Appellant Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals, Inc. and Boehringer Ingelheim USA Corporation, FILED. Service date 06/27/2023 by CM/ECF.[3534297] [23-881] [Entered: 06/27/2023 02:04 PM]
June 27, 2023 Filing 5 NOTICE OF APPEARANCE AS ADDITIONAL COUNSEL, on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC, FILED. Service date 06/27/2023 by CM/ECF. [3534248] [23-881] [Entered: 06/27/2023 01:35 PM]
June 20, 2023 Filing 4 CASE CALENDARING, for the week of 09/18/2023, A, PROPOSED.[3531137] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 06/20/2023 01:10 PM]
June 16, 2023 Opinion or Order Filing 3 ORDER, dated 06/16/2023, setting Appellant's brief due date as July 17, 2023 and Appellees' brief due date as August 17, 2023. The reply brief is due by August 28, 2023. The Clerk is directed to set the appeal for argument as early as the week of September 18, 2023., FILED.[3530582] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 06/16/2023 04:28 PM]
June 13, 2023 Filing 2 DISTRICT COURT ORDER, entered in the district court as docket entry dated 01/17/2023, RECEIVED.[3528604] [23-881] [Entered: 06/13/2023 02:10 PM]
June 13, 2023 Filing 1 NOTICE OF CIVIL APPEAL, with district court docket, on behalf of Appellant Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim USA Corporation, GlaxoSmithKline LLC, Glaxosmithkline Holdings (Americas), Inc., Pfizer, Inc., Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC, FILED. [3528601] [23-881] [Entered: 06/13/2023 02:06 PM]

Access additional case information on PACER

Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.

Search for this case: Corwin v. Boehringer Ingelheim Pharmaceuticals, Inc.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff / appellee: John Corwin
Represented By: John Bruegger Esq.
Represented By: Craig Archer Raabe Esq.
Represented By: Robert A. Izard Esq. Jr.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant / appellant: Boehringer Ingelheim Pharmaceuticals, Inc.
Represented By: Patrick M. Fahey Esq.
Represented By: James I. Glasser
Represented By: Jaime Ashley Welsh Esq.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant / appellant: Boehringer Ingelheim Corporation
Represented By: Patrick M. Fahey Esq.
Represented By: James I. Glasser
Represented By: Jaime Ashley Welsh Esq.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant / appellant: Boehringer Ingelheim USA Corporation
Represented By: Patrick M. Fahey Esq.
Represented By: James I. Glasser
Represented By: Jaime Ashley Welsh Esq.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant / appellant: GlaxoSmithKline LLC
Represented By: Lindsey Cohan Esq.
Represented By: Lauren R. Greenspoon Esq.
Represented By: Robert R. Simpson Esq.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant / appellant: Glaxosmithkline Holdings (Americas), Inc.
Represented By: Lindsey Cohan Esq.
Represented By: Lauren R. Greenspoon Esq.
Represented By: Robert R. Simpson Esq.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant / appellant: Pfizer, Inc.
Represented By: James O. Craven Esq.
Represented By: James I. Glasser
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant / appellant: Sanofi-Aventis U.S. LLC
Represented By: Anand Agneshwar Esq.
Represented By: Joseph W. Martini
Represented By: Daniel S. Pariser Esq.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant / appellant: Sanofi US Services Inc.
Represented By: Anand Agneshwar Esq.
Represented By: Joseph W. Martini
Represented By: Daniel S. Pariser Esq.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.

Why Is My Information Online?